Financial disclosure

The physicians have received compensation from Intuitive for consulting and/or educational services.

HCP opinion disclosure

Intuitive is sponsoring this presentation. The surgeons are presenting at the request of Intuitive and have received compensation from Intuitive for consulting and/or educational services. The views and opinions expressed are the surgeons alone and do not necessarily reflect the official policy or position of Intuitive. The information being presented is consistent with U.S. Food and Drug Administration guidelines, and other regulatory agencies around the world, and is not intended to promote the off-label use of the discussed product(s). All content is created and published for informational purposes only. It is not meant to offer medical, legal, accounting, regulatory compliance, or reimbursement advice and is not intended to establish a standard of care. Please consult professionals in these areas if you have related questions or concerns.

Important safety information

Serious complications may occur in any surgery, including da Vinci surgery, up to and including death. Serious risks include, but are not limited to, injury to tissues and organs and conversion to other surgical techniques which could result in a longer operative time and/or increased complications. For summary of the risks associated with surgery refer to www.intuitive.com/safety.

For product intended use and/or indications for use, risks, cautions, and warnings and full prescribing information, refer to the associated user manual(s) or visit https://manuals.intuitivesurgical.com/market.

Individual outcomes may depend on a number of factors—including but not limited to—patient characteristics, disease characteristics, and/or surgeon experience.

Da Vinci Xi/X

The demonstration of safety and effectiveness for the representative specific procedures did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease–free survival, local recurrence), except for radical prostatectomy which was evaluated for overall survival, or treatment of the patient’s underlying disease/condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon.

Da Vinci 5

For risks, cautions, and warnings and full prescribing information, refer to the associated da Vinci 5 Surgical System user manual(s).

Precaution for Representative Uses

The demonstration of safety and effectiveness for the representative–specific procedures was based on evaluation of the device as a surgical tool and did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease–free survival, local recurrence) or treatment of the patient’s underlying disease or condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon.